Buy or Sell: Hims & Hers Health Stock Prediction 2025 to 2030 Analyst Ratings

Insights:
Sharedhan- Stock Price Prediction [ Buy Sell Hold ] Analyst Recommendations

Today, we are going to forecast the Hims & Hers Health stock price prediction targets for 2025 to 2030 as part of a long-term outlook. We’ll also analyze the future potential of Hims & Hers Health stock, including whether it’s a good time to buy or sell. Additionally, we will consider analyst recommendations for the Hims & Hers Health stock prediction 2025.

Hims & Hers Health Stock Price Today


About Hims & Hers Health


Hims & Hers Health is a US-based telehealth company making healthcare easy and affordable. It offers online doctor consultations and personalized treatments for men and women, focusing on common issues like hair loss, skin care, sexual health, and mental wellness. Patients can connect with licensed doctors through a mobile app or website, get prescriptions, and have medicines delivered to their door.

The company aims to remove the embarrassment of discussing health problems and provides private, convenient care. Founded in 2017, Hims & Hers is growing fast, serving millions with quality healthcare at low costs.

Financial of Hims & Hers Health


Analyst: Hims & Hers Health Stock Prediction 2025


Target high is the top price analysts expect and target low is the lowest. Target mean is the average price and target mean is the average value. Recommendation mean (usually 1 = strong buy, 5 = strong sell) shows average rating and recommendation key shows overall view like underperform. Analyst count means Total number of analysts who gave their opinion.

Find Stock Prediction 2025

{{ content }}

To stay updated with the latest information related to the stock market and receive live stock market updates, follow Sharedhan and stay connected with us.

Google NewsFacebook
TelegramYoutube

Disclaimer: I would like to remind you that I am not authorized by SEC to provide any financial advice or recommendations. The Hims & Hers Health Stock Prediction are shared for informational purposes only. This does not count as a recommendation to buy, sell or hold the stock. Investors should do their own research, analysis and consult financial experts before making any investment decisions.

Disclaimer: This content is for education only, not financial advice. Do your own research. Sharedhan is not responsible for any profits or losses.